Corporate DisclosureORIONPHARM
ORIONPHARM Corporate Disclosure — 1 February 2024
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 1 February 2024. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Continuation news of ORIONPHARM): Consolidated NAV per share excluding revaluation surplus was Tk. 81.87 as on December 31, 2023 and Tk. 81.15 as on June 30, 2023. (end).
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
(ORIONPHARM-এর ধারাবাহিক খবর): পুনর্মূল্যায়ন উদ্বৃত্ত ব্যতীত শেয়ার প্রতি একত্রিত NAV ছিল টাকা। 31 ডিসেম্বর, 2023 অনুযায়ী 81.87 এবং টাকা 30 জুন, 2023 অনুযায়ী 81.15। (শেষ)।
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 65bb14e8edb49c4b75a15e9b
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.